cbdMD (NYSEAMERICAN:YCBD) Shares Down 7.6% – Should You Sell?

cbdMD, Inc. (NYSEAMERICAN:YCBD)’s stock price was down 7.6% during trading on Friday . The stock traded as low as $0.5602 and last traded at $0.5699. Approximately 231,445 shares were traded during mid-day trading, an increase of 2% from the average session volume of 226,930 shares. The stock had previously closed at $0.6170.

cbdMD Price Performance

The business has a 50-day simple moving average of $0.72 and a 200-day simple moving average of $0.81.

cbdMD (NYSEAMERICAN:YCBD) last released its quarterly earnings data on Thursday, May 14th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.03). cbdMD had a negative return on equity of 33.60% and a negative net margin of 13.29%.The firm had revenue of $5.64 million for the quarter, compared to analysts’ expectations of $5.29 million.

Hedge Funds Weigh In On cbdMD

A hedge fund recently bought a new stake in cbdMD stock. Jane Street Group LLC acquired a new position in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned about 0.49% of cbdMD at the end of the most recent quarter. Institutional investors own 7.18% of the company’s stock.

About cbdMD

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.